Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)

OBJECTIVE: This study determined whether two different formulations of hormone therapy (HT): oral conjugated equine estrogens (o-CEE; 0.45 mg/d, n = 209), transdermal 17β-estradiol (t-E2; 50 μg/d, n = 201) plus cyclic progesterone (Prometrium, 200 mg) or placebo (PBO, n = 243) affected sleep domains...

Descripción completa

Detalles Bibliográficos
Autores principales: Cintron, Dahima, Lahr, Brian D., Bailey, Kent R., Santoro, Nanette, Lloyd, Robin, Manson, JoAnn E., Neal-Perry, Genevieve, Pal, Lubna, Taylor, Hugh S., Wharton, Whitney, Naftolin, Fredrick, Harman, S. Mitchell, Miller, Virginia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771895/
https://www.ncbi.nlm.nih.gov/pubmed/28832429
http://dx.doi.org/10.1097/GME.0000000000000971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771895/
https://www.ncbi.nlm.nih.gov/pubmed/28832429
http://dx.doi.org/10.1097/GME.0000000000000971

Ejemplares similares